MET-3 is under development for the treatment of hypertriglyceridemia. It comprises live microbiota that normally reside in the human gut of a healthy individual. It is administered through oral route ...
PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...
India’s economy bounced back sharply after the pandemic-induced contraction. However, the job market hasn’t seen an equivalent improvement, thereby emerging as one of the big political-economy issues ...
Delhi experienced its worst air quality in eight years in 2023. Despite advancements like CNG vehicles and BS6 norms, air pollution remains high due to fossil fuel usage. Accelerating zero-emission ...